Insights

Growing Market Presence Epredia is a rapidly expanding global leader in precision cancer diagnostics, winning multiple prestigious awards in AI-assisted pathology solutions and digital pathology scanners, indicating strong industry recognition and increasing demand for innovative diagnostic tools.

Technological Leadership The company's recent awards for AI-enhanced pathology solutions and digital scanners highlight their focus on cutting-edge technology, presenting opportunities to collaborate with labs and hospitals seeking advanced diagnostic equipment and AI integration.

Strong Industry Partnerships Epredia's strategic partnerships with organizations like NovaScan and AbacusDx, along with regional awards and collaborations, suggest a receptive market for joint ventures, device distribution, and technology licensing in targeted healthcare settings.

Expanding Customer Base With significant customer trust demonstrated by over a billion product utilizations annually and awards recognizing laboratory efficiency improvements, there is substantial potential to upsell complementary diagnostic products and additional service contracts.

Market Opportunity Epredia's sizable revenue range and focus on precision diagnostics position it well to capitalize on the growing oncology diagnostics market, making it an attractive client for sales of advanced lab equipment, AI software solutions, and implementation services.

Epredia Tech Stack

Epredia uses 8 technology products and services including Twitter Ads, Power BI, SAP, and more. Explore Epredia's tech stack below.

  • Twitter Ads
    Advertising
  • Power BI
    Business Intelligence
  • SAP
    Customer Relationship Management
  • JD Edwards
    Enterprise
  • JavaScript
    Programming Languages
  • PRINCE2
    Project Management
  • Autoptimize
    Web Platform Extensions
  • Apache
    Web Servers

Media & News

Epredia's Email Address Formats

Epredia uses at least 1 format(s):
Epredia Email FormatsExamplePercentage
First.Last@epredia.comJohn.Doe@epredia.com
83%
First_Last@epredia.comJohn_Doe@epredia.com
11%
FirstLast@epredia.comJohnDoe@epredia.com
4%
FirLast@epredia.comJohDoe@epredia.com
2%

Frequently Asked Questions

Where is Epredia's headquarters located?

Minus sign iconPlus sign icon
Epredia's main headquarters is located at 20 Post Rd, Portsmouth, New Hampshire 03801, US. The company has employees across 6 continents, including North AmericaEuropeAsia.

What is Epredia's stock symbol?

Minus sign iconPlus sign icon
Epredia is a publicly traded company; the company's stock symbol is EPAM.

What is Epredia's official website and social media links?

Minus sign iconPlus sign icon
Epredia's official website is epredia.com and has social profiles on LinkedIn.

What is Epredia's SIC code NAICS code?

Minus sign iconPlus sign icon
Epredia's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Epredia have currently?

Minus sign iconPlus sign icon
As of October 2025, Epredia has approximately 1K employees across 6 continents, including North AmericaEuropeAsia. Key team members include Chief Manufacturing Officer, Amer: Z. B.Chief Strategy Officer (cso): B. L.Chief Manufacturing Officer -Emea: I. W.. Explore Epredia's employee directory with LeadIQ.

What industry does Epredia belong to?

Minus sign iconPlus sign icon
Epredia operates in the Biotechnology Research industry.

What technology does Epredia use?

Minus sign iconPlus sign icon
Epredia's tech stack includes Twitter AdsPower BISAPJD EdwardsJavaScriptPRINCE2AutoptimizeApache.

What is Epredia's email format?

Minus sign iconPlus sign icon
Epredia's email format typically follows the pattern of First.Last@epredia.com. Find more Epredia email formats with LeadIQ.

When was Epredia founded?

Minus sign iconPlus sign icon
Epredia was founded in 2019.

Epredia

Biotechnology ResearchUnited States1001-5000 Employees

Every second of every hour of every day, 44 of our products are employed in the battle against cancer. Customers put their trust in Epredia over a billion times every year. 

Epredia was established in July 2019 through an acquisition by PHC Group from Thermo Fisher Scientific. Powered by trusted brands such as Shandon, Microm, Menzel Gläser and Richard-Allan Scientific, Epredia has a wide breadth of solutions that have and will continue to transform the anatomical pathology market.

Today, we’re a global precision cancer diagnostics company working to improve patient outcomes by providing groundbreaking technologies. Since our humble beginnings in 1937, every product developed has been impacted by generations of employees who are committed to improving lives by enabling pathologists through enhancing precision cancer diagnostics.

Find out how you can improve lives while advancing your career at #Epredia by visiting epredia.com/careers. #WhatWeDoMatters

Section iconCompany Overview

Headquarters
20 Post Rd, Portsmouth, New Hampshire 03801, US
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
EPAM
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2019
Employees
1001-5000

Section iconFunding & Financials

  • $250M$500M

    Epredia's revenue is estimated to be in the range of $250M$500M

Section iconFunding & Financials

  • $250M$500M

    Epredia's revenue is estimated to be in the range of $250M$500M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.